JD HEALTH INTERNATIONAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.7 HKD | -2.29% |
|
-10.50% | -29.16% |
| Apr. 29 | China, HK stocks rise, led by property shares | RE |
| Apr. 11 | China stocks rise as commodities shine; Hong Kong snaps winning streak | RE |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 402,020 | 159,955 | 200,382 | 113,318 | 83,864 | - | - |
| Enterprise Value (EV) 1 | 369,839 | 118,166 | 154,618 | 113,318 | 64,538 | 57,325 | 52,047 |
| P/E ratio | -16.2 x | -143 x | 525 x | 52.3 x | 34.7 x | 26.7 x | 21 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 20.7 x | 5.21 x | 4.29 x | 2.12 x | 1.36 x | 1.16 x | 1.01 x |
| EV / Revenue | 19.1 x | 3.85 x | 3.31 x | 2.12 x | 1.04 x | 0.79 x | 0.63 x |
| EV / EBITDA | 976 x | -90.7 x | 877 x | 122 x | 37.8 x | 22.1 x | 14.7 x |
| EV / FCF | 101 x | 40.5 x | 26.4 x | - | 13.6 x | 8.85 x | 6.24 x |
| FCF Yield | 0.99% | 2.47% | 3.79% | - | 7.36% | 11.3% | 16% |
| Price to Book | 7.1 x | 3.89 x | 4.37 x | - | 1.59 x | 1.48 x | 1.37 x |
| Nbr of stocks (in thousands) | 3,184,367 | 3,194,617 | 3,179,915 | 3,188,615 | 3,189,465 | - | - |
| Reference price 2 | 126.2 | 50.07 | 63.01 | 35.54 | 26.29 | 26.29 | 26.29 |
| Announcement Date | 3/29/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 10,842 | 19,383 | 30,682 | 46,736 | 53,530 | 61,884 | 72,112 | 82,939 |
| EBITDA 1 | - | 378.9 | -1,303 | 176.3 | 928.2 | 1,706 | 2,596 | 3,545 |
| EBIT 1 | - | 351.7 | -1,366 | 35.6 | 894.4 | 1,519 | 2,567 | 3,779 |
| Operating Margin | - | 1.81% | -4.45% | 0.08% | 1.67% | 2.45% | 3.56% | 4.56% |
| Earnings before Tax (EBT) 1 | - | -17,072 | -901.5 | 695.8 | 2,693 | 3,007 | 3,818 | 4,808 |
| Net income 1 | -971.8 | -17,234 | -1,074 | 380.1 | 2,142 | 2,419 | 3,154 | 4,027 |
| Net margin | -8.96% | -88.92% | -3.5% | 0.81% | 4% | 3.91% | 4.37% | 4.86% |
| EPS 2 | - | -7.800 | -0.3500 | 0.1200 | 0.6800 | 0.7588 | 0.9832 | 1.249 |
| Free Cash Flow 1 | - | 3,662 | 2,921 | 5,865 | - | 4,750 | 6,481 | 8,345 |
| FCF margin | - | 18.89% | 9.52% | 12.55% | - | 7.68% | 8.99% | 10.06% |
| FCF Conversion (EBITDA) | - | 966.35% | - | 3,327.11% | - | 278.49% | 249.61% | 235.41% |
| FCF Conversion (Net income) | - | - | - | 1,542.99% | - | 196.38% | 205.48% | 207.23% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 11/25/20 | 3/29/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 Q2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 10,605 | 13,638 | 17,044 | 20,225 | 26,511 | 13,160 | 27,110 | 26,420 | 29,137 | 32,217 |
| EBITDA | - | - | -771.1 | - | - | - | - | - | - | - |
| EBIT | - | 597.4 | -808.5 | 1,201 | -185.6 | - | 943.9 | -243.2 | 794 | 1,176 |
| Operating Margin | - | 4.38% | -4.74% | 5.94% | -0.7% | - | 3.48% | -0.92% | 2.73% | 3.65% |
| Earnings before Tax (EBT) | - | - | -556.2 | 377.3 | 318.5 | - | 1,831 | 862.1 | 1,562 | 2,023 |
| Net income | - | -454.2 | -618.4 | 223 | 157.1 | - | 1,561 | 580.5 | 1,076 | 1,030 |
| Net margin | - | -3.33% | -3.63% | 1.1% | 0.59% | - | 5.76% | 2.2% | 3.69% | 3.2% |
| EPS | - | - | - | 0.0700 | 0.0500 | - | 0.4900 | 0.1900 | 0.3400 | 0.3200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/29/21 | 8/24/21 | 3/28/22 | 8/23/22 | 3/22/23 | 8/16/23 | 8/16/23 | 3/20/24 | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 32,181 | 41,789 | 45,764 | - | 19,326 | 26,539 | 31,817 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 3,662 | 2,921 | 5,865 | - | 4,750 | 6,481 | 8,345 |
| ROE (net income / shareholders' equity) | - | 3.86% | -2.71% | 0.9% | - | 5.88% | 6.81% | 7.77% |
| ROA (Net income/ Total Assets) | - | 2.85% | -2.33% | 0.7% | - | 3.4% | 4.21% | 4.76% |
| Assets 1 | - | -605,613 | 45,998 | 54,639 | - | 71,223 | 74,871 | 84,540 |
| Book Value Per Share 2 | - | 17.80 | 12.90 | 14.40 | - | 16.60 | 17.70 | 19.10 |
| Cash Flow per Share 2 | - | 1.680 | 1.110 | 1.880 | - | 1.570 | 1.920 | 2.180 |
| Capex 1 | - | 37.6 | 502 | 40.2 | - | 186 | 202 | 209 |
| Capex / Sales | - | 0.19% | 1.64% | 0.09% | - | 0.3% | 0.28% | 0.25% |
| Announcement Date | 11/25/20 | 3/29/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
26.29
CNY
Average target price
39.89
CNY
Spread / Average Target
+51.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.16% | 11.58B | |
| -36.92% | 14.21B | |
| +13.06% | 6.32B | |
| -27.59% | 6.51B | |
| -8.13% | 6.15B | |
| +71.17% | 4.98B | |
| -1.61% | 4.66B | |
| -6.68% | 3.97B | |
| -12.41% | 3.43B | |
| -9.81% | 2.96B |
- Stock Market
- Equities
- 6618 Stock
- Financials JD Health International Inc.
